Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
For further information, please see our References Tab above
Fifth, cost-effectiveness analyses are critical given the high price of current GLP-1 RAs and the large potential treatment population: preliminary health-economic models suggest acceptable cost-effectiveness ratios in high-fibrosis patients with comorbid type 2 diabetes and cardiovascular disease, but robust data in broader MASLD populations are lacking
There are no unit conversions needed because you are not drawing from a vial
This add-on is perfect for clients experiencing nausea from migraines, hangovers, travel, or post-workout recovery
US$ 21.40
US$ 29.94
US$ 22.61
US$ 29.06
US$ 27.21
US$ 23.05
